Safety study in kids and [br-m] teens

h1
center
text-brand-navy
font-weight-extrabold
24
24
false
A 1-year safety study looked at how well kids and teens (aged 6-17) with ADHD tolerated Simtriyo. This study included participants who completed the first trials and those who were newly enrolled. The participants knew they were taking Simtriyo, which could have influenced the study results.
text-center
text-brand-navy
font-weight-medium
size-medium
link-color-orange
916px
48
custom
40
false
1060px
20px
16px
true
row
row
center
For most kids and teens in the study, the safety experience after 1 year was consistent with the main studies. The most common side effects in the safety study were decreased appetite, headache, upper respiratory tract infection, nausea, and decreased weight.
custom
#F5F3ED
#002c3e
-1
center
48
custom
39
false
Improvement in symptoms was maintained for most people through 1 year of study.
text-center
text-brand-navy
font-weight-medium
size-medium
link-color-orange
916px
custom
20
24
false
Symptom improvement was not the main goal of the 1-year safety study and does not carry the same weight as the main goals of the [br-m] study.
text-center
text-brand-navy
font-weight-medium
size-medium
link-color-orange
702px